All Pathways
Infectious DiseaseManagement

Central Line-Associated Bloodstream Infection Management

Central Line-Associated Bloodstream Infection Management: Suspected CLABSI → Blood Cultures → Empiric Antibiotics → Remove Central Line? → LINE REMOVAL ...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected CLABSI

    Bacteremia + central line with no other source

    1. Action

      Blood Cultures

      Paired peripheral and catheter cultures

      • At least 2 sets from different sites
      • One from catheter hub, one peripheral
      • Differential time to positivity may help diagnosis
      1. Action

        Empiric Antibiotics

        Cover gram-positive, consider gram-negative

        • Vancomycin 15-20mg/kg IV q8-12h
        • ADD Gram-negative coverage if: Severe sepsis, immunocompromised, femoral line
        • Piperacillin-tazobactam or Cefepime
        1. Decision

          Remove Central Line?

          Preferred for most CLABSI

          1. Action

            LINE REMOVAL Recommended

            For most situations

            • S. aureus: Always remove
            • Candida: Always remove
            • P. aeruginosa: Always remove
            • Tunnel infection/port abscess: Remove
            • Septic shock/endocarditis: Remove
            1. Decision

              Organism Identification

              1. Action

                S. aureus

                High risk for complications

                • Remove line (mandatory)
                • TEE for endocarditis
                • Duration: 4-6 weeks if complicated, 2 weeks if uncomplicated
                • MSSA: Nafcillin; MRSA: Vancomycin/Daptomycin
                1. Action

                  Echocardiogram

                  TEE preferred for S. aureus

                  • Recommended for all S. aureus CLABSI
                  • Consider for persistent bacteremia
                  • Assess for endocarditis
                  1. Outcome

                    Resolved

                    Negative cultures, completed therapy

                  2. Warning

                    Complications

                    Endocarditis, septic thrombosis, metastatic infection

              2. Action

                Coag-Negative Staph

                Most common pathogen

                • Can attempt salvage if uncomplicated
                • Duration: 5-7 days if line removed
                • 10-14 days if line retained + lock therapy
              3. Action

                Candida

                Fungemia

                • Remove line (mandatory)
                • Echinocandin: Caspofungin, Micafungin, or Anidulafungin
                • Duration: 14 days from first negative culture
                • Dilated eye exam for endophthalmitis
              4. Action

                Gram-Negative Rod

                P. aeruginosa high-risk

                • Pseudomonas: Remove line, 7-14 days
                • Enterobacteriaceae: 7-14 days
                • Targeted therapy based on susceptibilities
          2. Action

            Salvage (Keep Line)

            Limited situations only

            • CoNS without complications
            • No tunnel infection, no endocarditis
            • Line is critical/difficult to replace
            • Antibiotic lock therapy + systemic antibiotics

Guideline Source

IDSA Intravascular Catheter-Related Infection Guidelines 2009

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • ⚠️ UNVALIDATED DRAFT: This algorithm was AI-generated from guideline summaries and has NOT been reviewed by clinical experts. All doses, thresholds, and pathways MUST be verified against primary sources by qualified clinicians before clinical use. Do not use for patient care without expert validation.
  • Line removal recommended for most infections
  • Salvage therapy decision is complex
  • Tunnel/port infections need surgery

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Central Line-Associated Bloodstream Infection Management?

The Central Line-Associated Bloodstream Infection Management is a management clinical algorithm for Infectious Disease. It provides a structured decision tree to guide clinical decision-making, based on IDSA Intravascular Catheter-Related Infection Guidelines 2009.

What guideline is the Central Line-Associated Bloodstream Infection Management based on?

This algorithm is based on IDSA Intravascular Catheter-Related Infection Guidelines 2009 (DOI: 10.1086/599376).

What are the limitations of the Central Line-Associated Bloodstream Infection Management?

Known limitations include: ⚠️ UNVALIDATED DRAFT: This algorithm was AI-generated from guideline summaries and has NOT been reviewed by clinical experts. All doses, thresholds, and pathways MUST be verified against primary sources by qualified clinicians before clinical use. Do not use for patient care without expert validation.; Line removal recommended for most infections; Salvage therapy decision is complex; Tunnel/port infections need surgery. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Central Line-Associated Bloodstream Infection Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free